Roger Medel M.D., Director at MEDNAX, INC. (MD), sold 1,270 shares at $29.00 ($37K) on 2021-10-04, disclosed to the SEC on 2021-10-06.
Scheduled sale ($37k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MD | SELL | 2022-01-04 | $5.1M | — | Filing → |
| MD | SELL | 2021-12-30 | $2.5M | — | Filing → |
| MD | SELL | 2021-12-29 | $6.7M | — | Filing → |